
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1041 | 1041 | 1078 | 1235 | 1779 | 2636 |
Fund Return | 4.07% | 4.07% | 7.84% | 7.28% | 12.22% | 10.18% |
Place in category | 290 | 290 | 333 | 356 | 360 | 38 |
% in Category | 19 | 19 | 22 | 32 | 38 | 6 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Income Fund B Accumulation | 14.18M | 6.90 | 9.68 | 10.52 | ||
Income Fund Sterling Accumulation | 3.72M | 3.86 | 6.41 | 9.28 | ||
Income Fund B Income | 47.8M | 6.90 | 9.68 | 10.52 | ||
Income Fund Institutional W Accumul | 636.41M | 6.93 | 9.84 | 10.71 | ||
Income Fund Institutional W Income | 843.91M | 6.93 | 9.84 | 10.71 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Guinness Global Equity Income Z | 6.29B | -0.49 | 8.77 | 11.02 | ||
Fidelity Global Dividend Fund A ACC | 3.25B | 3.42 | 8.63 | 8.88 | ||
Fidelity Global Dividend Fund W Acc | 3.25B | 3.62 | 9.45 | 9.69 | ||
Fidelity Global Dividend Fund W Inc | 3.25B | 3.62 | 9.46 | 9.72 | ||
Income Fund Sterling Accumulation | 3.72M | 3.86 | 6.41 | 9.28 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
CME Group | US12572Q1058 | 3.43 | 263.69 | +0.82% | |
Sanofi | FR0000120578 | 3.09 | 91.88 | +2.52% | |
Medtronic | IE00BTN1Y115 | 2.55 | 84.22 | +1.59% | |
Cisco | US17275R1023 | 2.51 | 57.43 | +0.17% | |
AstraZeneca | GB0009895292 | 2.42 | 10,320.0 | +3.12% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review